Literature DB >> 16020359

Efficacy of occlusion treatment in amblyopia and clinical risk factors affecting the results of treatment.

Gul Arikan1, Aylin Yaman, A Tulin Berk.   

Abstract

PURPOSE: To evaluate the factors influencing visual outcome in strabismic, strabismic-anisometropic and anisometropic amblyopia following occlusion treatment.
METHODS: Records of 128 pediatric patients who had been treated for amblyopia by occlusion of the fellow eye between March 1992 and March 2003 were reviewed retrospectively. Age and level of visual acuity at initiation of treatment, occlusion time (full-time, part-time or minimal) and type of amblyopia were analyzed for the effect on visual outcome.
RESULTS: The mean age of the patients was 5.69 +/- 2.01 years (3 to 12 years). Mean follow-up time was 3 years 2 months (6 months to 10 years). Mean visual acuity improvements were similar for the subtypes of amblyopia (strabismic amblyopia 0.38 +/- 0.29 logMAR units, strabismic-anisometropic amblyopia 0.46 +/- 0.40 logMAR units, anisometropic amblyopia 0.35 +/- 0.24 logMAR units). Level of initial visual acuity, age at initiation of treatment and type of occlusion correlated with the final visual acuity (p = 0.000, p = 0.035, p = 0.012, respectively). When the analysis was performed according to the subtypes of amblyopia, initial visual acuity was the only factor associated with the final visual acuity in all types of amblyopia (p < 0.05).
CONCLUSION: The level of initial visual acuity is the most significant factor determining the success of treatment in amblyopia.

Entities:  

Mesh:

Year:  2005        PMID: 16020359     DOI: 10.1080/09273970590922682

Source DB:  PubMed          Journal:  Strabismus        ISSN: 0927-3972


  8 in total

1.  Characterization of Bangerter filter effect in mild and moderate anisometropic amblyopia: predictive factors for the visual outcome.

Authors:  Carlos Laria; David P Piñero; Jorge L Alió
Journal:  Graefes Arch Clin Exp Ophthalmol       Date:  2010-11-19       Impact factor: 3.117

2.  Fixation instability, astigmatism, and lack of stereopsis as factors impeding recovery of binocular balance in amblyopia following binocular therapy.

Authors:  Éva M Bankó; Mirella Telles Salgueiro Barboni; Katalin Markó; Judit Körtvélyes; János Németh; Zoltán Zs Nagy; Zoltán Vidnyánszky
Journal:  Sci Rep       Date:  2022-06-20       Impact factor: 4.996

3.  "Combined Occlusion and Atropine Therapy" Versus "Augmented Part-Time Patching" in Children with Refractory/Residual Amblyopia: A Pilot Study.

Authors:  Virender Sachdeva; Vaibhev Mittal; Varun Gupta; Rekha Gunturu; Ramesh Kekunnaya; Anjali Chandrasekharan; Preeti Patil Chabblani; Harsha L Rao
Journal:  Middle East Afr J Ophthalmol       Date:  2016 Apr-Jun

Review 4.  Part-time versus full-time occlusion therapy for treatment of amblyopia: A meta-analysis.

Authors:  Negareh Yazdani; Ramin Sadeghi; Hamed Momeni-Moghaddam; Leili Zarifmahmoudi; Asieh Ehsaei; Brendan T Barrett
Journal:  J Curr Ophthalmol       Date:  2017-03-06

5.  Macular Thickness, Foveal Volume, and Choroidal Thickness in Amblyopic Eyes and Their Relationships to the Treatment Outcome.

Authors:  Chun-Hsiu Liu; Sherine Jue Ong; Chung-Ying Huang; Wei-Chi Wu; Ling-Yuh Kao; Meng-Ling Yang
Journal:  J Ophthalmol       Date:  2018-08-06       Impact factor: 1.909

6.  Full time occlusion VS part time occlusion in treatment of monocular amblyopia.

Authors:  Mohammad Asim Mehboob; Shoaib Muhammad; Muhammad Asad Farooq
Journal:  Pak J Med Sci       Date:  2019 Nov-Dec       Impact factor: 1.088

Review 7.  Management of amblyopia in pediatric patients: Current insights.

Authors:  Sagnik Sen; Pallavi Singh; Rohit Saxena
Journal:  Eye (Lond)       Date:  2021-07-07       Impact factor: 3.775

8.  Portable rotating grating stimulation for anisometropic amblyopia with 6 months training.

Authors:  Wen-Hsiu Yeh; Li-Ju Lai; Da-Wei Chang; Wei-Sin Lin; Guan-Ming Lin; Fu-Zen Shaw
Journal:  Sci Rep       Date:  2021-06-01       Impact factor: 4.379

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.